Skip to search formSkip to main contentSkip to account menu

equol, (-)-

Known as: S-equol, (-)-Equol, (3S)-3,4-dihydro-3-(4-hydroxyphenyl)-2H-1-benzopyran-7-ol 
An orally bioavailable, non-steroidal estrogen naturally produced by the metabolism of the isoflavonoid daidzein by human intestinal microflora, with… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
INTRODUCTION AND OBJECTIVES: Central obesity is known to be involved in benign prostatic hyperplasia (BPH). Some study reports… 
2014
2014
Trabajo presentado en el V Workshop Probioticos, Prebioticos y Salud: Evidencia Cientifica, celebrado en Valencia el 23 y 24 de… 
2014
2014
Objective To study the protective effects of S‐equol on oxidative stress‐induced cell injury in human umbilical vein endothelial… 
2013
2013
Introduction: Osteoporosis was long considered to be women desease. Studies have shown the importance of further research on the… 
2012
2012
Previous studies have suggested that the daidzein metabolite equol rather than daidzein itself contributes to the beneficial… 
2012
2012
Estradiol (E2) is a very potent cytoprotectant against a wide variety of cellular insults in numerous different cell models… 
2010
2010
This summary addresses the progress and limitations of existing research on the physiologic properties of the isoflavone daidzein… 
2010
2010
S‐equol is an intestinal bacterial metabolite of daidzein. S‐equol is produced by 50% of Japanese but only 30% of North Americans… 
2001
2001
The capacity to convert the soy isoflavone daidzein to equol in vivo is presumably determined by an individual’s intestinal…